biotech
biotech Articles
Shares of Repros Therapeutics climbed in Thursday’s session after the company announced results from its mid-stage study for women with moderate to severe confirmed endometriosis.
Published:
Last Updated:
24/7 Wall St. has been concerned about the longer-term implications of GW Pharma over other emerging drug and biotech outfits.
Published:
Last Updated:
24/7 Wall St. has collected several big FDA decisions and mid-to-late-stage trials that should be coming up in October. These catalyst events can make or break these companies.
Published:
Last Updated:
Celgene is making a move out of left field that has sent shares of its partner Agios Pharmaceuticals significantly higher.
Published:
Last Updated:
Shares of Retrophin climbed early on Wednesday following positive top-line news from its mid-stage trial for the treatment of focal segmental glomerulosclerosis.
Published:
Last Updated:
Tonix Pharmaceuticals was the disaster of the day on Tuesday after the company announced that it will stop development of its fibromyalgia treatment after it failed in a late-stage trial.
Published:
Last Updated:
What most investors are looking for is a solid solution in what is a confusing market. So we have compiled a list of a few biotech companies that fit the bill, and analysts are saying they can fill...
Published:
Last Updated:
One election year hot-button issue that is back on the table is the ongoing fight over drug prices. But the public has been debating drug prices for years now — long before the EpiPen price hike...
Published:
Last Updated:
24/7 Wall St. has collected several big FDA decisions and mid-to-late-stage trials that should be coming up in September.
Published:
Last Updated:
Shares of Cynapsus Therapeutics more than doubled on Thursday after it was announced that Sunovion Pharmaceuticals would be acquiring the company.
Published:
Last Updated:
In a new research report, Baird notes two biotech companies in its research coverage universe that may be considered speculative takeover targets, and a third is a possible target as well.
Published:
Last Updated:
Shares of Array BioPharma saw a handy gain in Tuesdays session following the announcement of mid-stage results from its cardiomyopathy trial.
Published:
Last Updated:
The August 15 short interest data have been compared with the previous report, and short interest moves were mixed across these selected biotech stocks.
Published:
Last Updated:
Clovis Oncology shares saw a massive gain on Tuesday, on the heels of news that the FDA had granted it a priority review of its cancer drug.
Published:
Clovis Oncology, Inc. (NASDAQ: CLVS) is watching its shares climb late Tuesday after the company announced a key U.S. Food and Drug Administration (FDA) approval. Note that this is the first of a few...
Published:
Last Updated: